A functional single‐nucleotide polymorphism in the ERCC1 gene alters the efficacy of narrowband ultraviolet B therapy in patients with active vitiligo in a Chinese population
A functional single‐nucleotide polymorphism in the ERCC1 gene alters the efficacy of narrowband ultraviolet B therapy in patients with active vitiligo in a Chinese population
复制标题
DOI:
10.1111/bjd.13892
复制
发表时间:
2015-08
影响因子:
10.3
通讯作者:
W. Dai;Fubo Zhou;Chao Wei;Xiaowen Wang;Shuzhong Guo;X. Yi;Kai Li;Tianwen Gao;Ling Liu;C. Li
中科院分区:
文献类型:
--
作者:
W. Dai;Fubo Zhou;Chao Wei;Xiaowen Wang;Shuzhong Guo;X. Yi;Kai Li;Tianwen Gao;Ling Liu;C. Li
T lymphocytes have been shown to cause the destruction of melanocytes in vitiligo pathogenesis. Narrowband ultraviolet B (NB‐UVB), as an effective therapeutic strategy in vitiligo, can lead to the formation of DNA photoproducts such as cyclobutane pyrimidine dimers (CPDs) in perilesional lymphocytes and thus induce skin immunosuppression. The repair of DNA photoproducts is performed mainly through the nucleotide excision repair (NER) pathway. We hypothesized that single‐nucleotide polymorphisms (SNPs) in NER genes might influence the repair capacity of CPDs and thus contribute to variations in phototherapy efficiency.